General Information of Drug-Metabolizing Enzyme (DME ID: DME0195)
DME Name Phosphodiesterase 5A (PDE5A), Homo sapiens DME Info
UniProt ID
PDE5A_HUMAN
EC Number    EC: 3.1.4.35     (Click to Show/Hide the Complete EC Tree)
Hydrolases
Ester bond hydrolase
Phosphoric diester hydrolase
EC: 3.1.4.35
Lineage    Species: Homo sapiens     (Click to Show/Hide the Complete Species Lineage)
Kingdom: Metazoa
Phylum: Chordata
Class: Mammalia
Order: Primates
Family: Hominidae
Genus: Homo
Species: Homo sapiens
Interactome
Disease Specific Interactions between Host Protein and DME (HOSPPI)
      ICD Disease Classification 02 Neoplasms
               ICD-11: 2C12 Liver cancer Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Liver cancer Moderate hypermethylation
Interaction Name DNMT-PDE5A interaction
The Methylation Level of Disease Section Compare with the Other Disease Section Moderate hypermethylation
p-value: 1.20E-02; delta-beta: 2.40E-02
Description DNA methyltransferase (DNMT) is reported to moderatly hyper-methylate the PDE5A gene, which leads to a moderatly decreased expression of the drug-metabolizing enzyme Phosphodiesterase 5A. As a result, the interaction between DNMT and PDE5A can moderatly affect the drug-metabolizing process of Phosphodiesterase 5A.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue adjacent to the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
DME methylation in tissue other than the diseased tissue of patients
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
               ICD-11: 2C30 Melanoma Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     Transcription-factor regulation
                            Octamer-binding protein 7 (POU3F2) Melanoma Repression
Uniprot ID
PO3F2_HUMAN
Interaction Name POU3F2-PDE5A interaction [1]
Studied Cell Lines WM266.4, A375P, A375M2, Skeml28, Skmel24, Colo829, Skeml5, Skmel13, MEL-HO, 501mel and 4599 cell lines
Ensembl ID
ENSG00000184486
Description Octamer-binding protein 7 (POU3F2) is reported to repress the transcription of PDE5A gene, which leads to a decreased expression of the drug-metabolizing enzyme Phosphodiesterase 5A. As a result, the interaction between POU3F2 and PDE5A can repress the drug-metabolizing process of Phosphodiesterase 5A.
               ICD-11: 2E06 Prostate cancer metastasis Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Prostate cancer metastasis Significant hypomethylation
Interaction Name DNMT-PDE5A interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 1.15E-02; delta-beta: -3.36E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the PDE5A gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Phosphodiesterase 5A. As a result, the interaction between DNMT and PDE5A can significantly affect the drug-metabolizing process of Phosphodiesterase 5A.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
      ICD Disease Classification 05 Endocrine/nutritional/metabolic diseases
               ICD-11: 5B81 Obesity Click to Show/Hide the Full List of HOSPPI:        1 HOSPPI
                     DNA methylation
                            DNA methyltransferase (DNMT) Obesity Significant hypomethylation
Interaction Name DNMT-PDE5A interaction
The Methylation Level of Disease Section Compare with the Healthy Individual Tissue Significant hypomethylation
p-value: 2.57E-08; delta-beta: -3.56E-01
Description DNA methyltransferase (DNMT) is reported to significantly hypo-methylate the PDE5A gene, which leads to a significantly increased expression of the drug-metabolizing enzyme Phosphodiesterase 5A. As a result, the interaction between DNMT and PDE5A can significantly affect the drug-metabolizing process of Phosphodiesterase 5A.
DME methylation in the diseased tissue of patients
DME methylation in the normal tissue of healthy individuals
Violin Diagram of DME Disease-specific Methylation Level Click to View the Clearer Original Diagram
References
1 Oncogenic BRAF induces melanoma cell invasion by downregulating the cGMP-specific phosphodiesterase PDE5A. Cancer Cell. 2011 Jan 18;19(1):45-57.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.